October 25, 2016 11:14 PM ET


Company Overview of NGM Biopharmaceuticals, Inc.

Key Executives for NGM Biopharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
William J. Rieflin 11 RelationshipsChief Executive Officer and Director56
Jeffrey D. Jonker J.D.No RelationshipsPresident43
Jin-Long Chen Ph.D.11 RelationshipsFounder, Chief Scientific Officer and Director53
David Woodhouse Ph.D.No RelationshipsChief Financial Officer--
Aetna Wun Trombley Ph.D.4 RelationshipsChief Operating Officer and Vice President--
View More Key Executives

NGM Biopharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David V. Goeddel Ph.D. 66 RelationshipsIgenica, Inc.64
William J. Rieflin 11 RelationshipsNGM Biopharmaceuticals, Inc.56
Jin-Long Chen Ph.D. 11 RelationshipsNGM Biopharmaceuticals, Inc.53
Michael S. Brown M.D. 34 RelationshipsPeloton Therapeutics, Inc.75
McHenry T. Tichenor Jr. 11 RelationshipsTichenor Ventures, LLC60
View All Board Members

NGM Biopharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D.Michael S. Brown34 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
NGM Biopharmaceuticals, Inc. CEO Compensation
Industry Average


Global Blood Therapeutics, Inc. Announces Resignation of Dr. Eleanor Ramos as Chief Medical Officer
October 24, 2016 8:34 PM ET
GenVec, Inc. Announces Board Changes
October 24, 2016 8:33 PM ET
Gradalis, Inc. Appoints Brian Daniels to its Scientific Advisory Board
October 24, 2016 4:19 PM ET
OncBioMune Pharmaceuticals, Inc. Appoints Brian Barnett to its Scientific Advisory Board
October 24, 2016 2:47 PM ET
Stellar Biotechnologies, Inc. Appoints Gregory T. Baxter as Vice President of Corporate Development and Communications, Effective December 1, 2016
October 24, 2016 11:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NGM Biopharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.